Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma.
Australas J Dermatol
; 58(4): 256-258, 2017 Nov.
Article
en En
| MEDLINE
| ID: mdl-29064087
ABSTRACT
Sentinel lymph node (SLN) status has been advocated in several recently published articles as the single most valuable prognostic marker for melanoma, and of greater prognostic importance than more established parameters such as Breslow thickness. A careful examination of the evidence for these claims, however, indicates that they are not substantiated by the available data, are somewhat misleading and suggest misinterpretation of the statistical analysis of the papers to which they refer. We will examine the basis for these claims and show why they are invalid.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Estadística como Asunto
/
Ganglio Linfático Centinela
/
Melanoma
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Australas J Dermatol
Año:
2017
Tipo del documento:
Article
País de afiliación:
Australia